- Home
- TBHC vs SCNX Comparison
TBHC vs SCNX Comparison
Compare TBHC & SCNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TBHC | SCNX |
|---|---|---|
| Founded | 1966 | 2010 |
| Country | United States | United States |
| Employees | 4010 | 19 |
| Industry | Other Specialty Stores | Other Pharmaceuticals |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 21.9M | 19.0M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | TBHC | SCNX |
|---|---|---|
| Price | $0.92 | $0.41 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $1.50 |
| AVG Volume (30 Days) | 45.7K | ★ 302.5K |
| Earning Date | 04-30-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $1,097.38 |
| Revenue Next Year | N/A | $239.80 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.86 | $0.24 |
| 52 Week High | $2.40 | $2.60 |
Technical Indicators
Market Signals| Indicator | TBHC | SCNX |
|---|---|---|
| Relative Strength Index (RSI) | 42.69 | 51.19 |
| Support Level | N/A | $0.37 |
| Resistance Level | $1.27 | $0.47 |
| Average True Range (ATR) | 0.05 | 0.03 |
| MACD | 0.00 | -0.00 |
| Stochastic Oscillator | 47.00 | 22.54 |
Price Performance
Historical ComparisonAbout TBHC The Brand House Collective Inc.
The Brand House Collective Inc is a specialty retailer of home decor and gifts in the United States. The company stores provide various merchandise, including holiday decor, value pricing, and a stimulating in-store and online environment that provides customers with a brand experience. The company stores also offer an assortment of holiday merchandise in seasonal periods, as well as items that are suitable for gift-giving.
About SCNX Scienture Holdings Inc.
Scienture Holdings Inc is a comprehensive health services and pharmaceutical product company. The group focused on providing value to patients and caregivers by offering novel specialty products to satisfy unmet market needs and optimize the prescription journey and patient engagement in the U.S.